相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Phosphatase PHLPP2 Plays a Key Role in the Regulation of Pancreatic Beta-Cell Survival
Marta Letizia Hribal et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)
Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis
Hongming Zhang et al.
ONCOTARGETS AND THERAPY (2020)
m6A-dependent glycolysis enhances colorectal cancer progression
Chaoqin Shen et al.
MOLECULAR CANCER (2020)
Tripartite Motif-Containing 46 Promotes Viability and Inhibits Apoptosis of Osteosarcoma Cells by Activating NF-κB Signaling Through Ubiquitination of PPARα
Wenwei Jiang et al.
ONCOLOGY RESEARCH (2020)
A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis
Yanlu Xiong et al.
BMC CANCER (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression
Junli Deng et al.
BMC CANCER (2019)
Copy number variation is highly correlated with differential gene expression: a pan-cancer study
Xin Shao et al.
BMC MEDICAL GENETICS (2019)
The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism
Karolien Vanhove et al.
FRONTIERS IN ONCOLOGY (2019)
Tripartite motif-containing 15 overexpression in non-small cell lung cancer is associated with poor patient prognoses
Xiaoying Han et al.
JOURNAL OF CANCER (2019)
The challenge of drug resistance in cancer treatment: a current overview
Michail Nikolaou et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein
Minggang Peng et al.
ONCOGENE (2018)
Inhibition of GLUT-I expression and the PI3K/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro
Tao Jiang et al.
ONCOTARGETS AND THERAPY (2018)
The epidemiology of lung cancer
Patricia M. de Groot et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
High Expression of Glycolytic Genes in Cirrhosis Correlates With the Risk of Developing Liver Cancer
Nathan C. W. Lee et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
RING-Finger Protein 6 Amplification Activates JAK/STAT3 Pathway by Modifying SHP-1 Ubiquitylation and Associates with Poor Outcome in Colorectal Cancer
Qian Liang et al.
CLINICAL CANCER RESEARCH (2018)
EGFR gene copy number as a predictive/biomarker for patients with non-small-cell lung cancer receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis
Xin Zhang et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2017)
Chemoresistance and targeted therapies in ovarian and endometrial cancers
Kevin Brasseur et al.
ONCOTARGET (2017)
miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer
Michaela Strotbek et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Copy number variation, increased gene expression, and molecular mechanisms of neurofascin in lung cancer
Johanna Samulin Erdem et al.
MOLECULAR CARCINOGENESIS (2017)
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition
Justin Goodwin et al.
NATURE COMMUNICATIONS (2017)
Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis
Wei Li et al.
ONCOTARGET (2017)
MiR-488 inhibits proliferation and cisplatin sensibility in non-smallcell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
Chao Fang et al.
SCIENTIFIC REPORTS (2017)
The Glycolytic Switch in Tumors: How Many Players Are Involved?
Li Yu et al.
JOURNAL OF CANCER (2017)
TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer
Anna C. Groner et al.
CANCER CELL (2016)
Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
Huanan Wang et al.
CANCER CELL INTERNATIONAL (2016)
Metabolic Heterogeneity in Human Lung Tumors
Christopher T. Hensley et al.
CELL (2016)
PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases
Marta Letizia Hribal et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Novel therapeutic targets on the horizon for lung cancer
Wan-Ling Tan et al.
LANCET ONCOLOGY (2016)
MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism
Chenwei Pan et al.
PLOS ONE (2016)
PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma
Baobiao Zhuo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
PHLPP2 Downregulation Contributes to Lung Carcinogenesis Following B[a]P/B[a]PDE Exposure
Haishan Huang et al.
CLINICAL CANCER RESEARCH (2015)
TRIM46 Controls Neuronal Polarity and Axon Specification by Driving the Formation of Parallel Microtubule Arrays
Sam F. B. van Beuningen et al.
NEURON (2015)
Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy
Xue-bing Li et al.
THORACIC CANCER (2015)
17β-Estradiol Activates Glucose Uptake via GLUT4 Translocation and PI3K/Akt Signaling Pathway in MCF-7 Cells
Pablo Garrido et al.
ENDOCRINOLOGY (2013)
PHUPPing the switch on Akt and protein kinase C signaling
John Brognard et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2008)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
分享论文
